vTv Therapeutics (VTVT) Tops Q1 EPS by 165c

vTv Therapeutics (NASDAQ: VTVT) reported Q1 EPS of $1.65. Revenue for the quarter came in at $36.84 million.

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Are we witnessing a fundamental or speculative rally in the S&P 500?
• RBC Capital on Veeva Systems (VEEV) Amid After Hours Selloff on Earnings: 'we are surprised to see shares trade down'